Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |